[1]
|
Asrani, S.K., Devarbhavi, H., Eaton, J., et al. (2019) Burden of Liver Diseases in the World. Journal of Hepatology, 70, 151-171. https://doi.org/10.1016/j.jhep.2018.09.014
|
[2]
|
Yang, Y.M., Kim, S.Y. and Seki, E. (2019) Inflammation and Liver Cancer: Molecular Mechanisms and Therapeutic Targets. Seminars in Liver Disease, 39, 26-42. https://doi.org/10.1055/s-0038-1676806
|
[3]
|
Li, Y., Lu, L. and Cai, X. (2021) Liver Regeneration and Cell Transplantation for End-Stage Liver Disease. Biomolecules, 11, Article No. 1907. https://doi.org/10.3390/biom11121907
|
[4]
|
Zhang, L., Ma, X.J., Fei, Y.Y., et al. (2022) Stem Cell Therapy in Liver Regeneration: Focus on Mesenchymal Stem Cells and Induced Pluripotent Stem Cells. Pharmacology & Thera-peutics, 232, Article ID: 108004.
https://doi.org/10.1016/j.pharmthera.2021.108004
|
[5]
|
Messina, A., Luce, E., Hussein, M., et al. (2020) Pluripo-tent-Stem-Cell-Derived Hepatic Cells: Hepatocytes and Organoids for Liver Therapy and Regeneration. Cells, 9, Article No. 420. https://doi.org/10.3390/cells9020420
|
[6]
|
Zakrzewski, W., Dobrzynski, M., Szymonowicz, M., et al. (2019) Stem Cells: Past, Present, and Future. Stem Cell Research & Therapy, 10, Article No. 68. https://doi.org/10.1186/s13287-019-1165-5
|
[7]
|
Wagers, A.J. and Weissman, I.L. (2004) Plasticity of Adult Stem Cells. Cell, 116, 639-648.
https://doi.org/10.1016/S0092-8674(04)00208-9
|
[8]
|
Evans, M.J. and Kaufman, M.H. (1981) Establishment in Culture of Pluripotential Cells from Mouse Embryos. Nature, 292, 154-156. https://doi.org/10.1038/292154a0
|
[9]
|
Kuai, X.L., Shao, N., Lu, H., et al. (2014) Differentiation of Nonhuman Primate Embryonic Stem Cells into Hepatocyte-Like Cells. Journal of Digestive Diseases, 15, 27-34. https://doi.org/10.1111/1751-2980.12103
|
[10]
|
Brolen, G., Sivertsson, L., Bjorquist, P., et al. (2010) Hepato-cyte-Like Cells Derived from Human Embryonic Stem Cells Specifically via Definitive Endoderm and a Progenitor Stage. Journal of Biotechnology, 145, 284-294.
https://doi.org/10.1016/j.jbiotec.2009.11.007
|
[11]
|
Wang, J., Sun, M., Liu, W., et al. (2019) Stem Cell-Based Therapies for Liver Diseases: An Overview and Update. Journal of Tissue Engineering and Regenerative Medicine, 16, 107-118. https://doi.org/10.1007/s13770-019-00178-y
|
[12]
|
Takase, H.M., Itoh, T., Ino, S., et al. (2013) FGF7 Is a Functional Niche Signal Required for Stimulation of Adult Liver Progenitor Cells That Support Liver Regeneration. Genes & Development, 27, 169-181.
https://doi.org/10.1101/gad.204776.112
|
[13]
|
Virovic-Jukic, L., Ljubas, D., Stojsavljevic-Shapeski, S., et al. (2022) Liver Regeneration as Treatment Target for Severe Alcoholic Hepatitis. World Journal of Gastroenterology, 28, 4557-4573. https://doi.org/10.3748/wjg.v28.i32.4557
|
[14]
|
Terai, S., Ishikawa, T., Omori, K., et al. (2006) Im-proved Liver Function in Patients with Liver Cirrhosis after Autologous Bone Marrow Cell Infusion Therapy. Stem Cells, 24, 2292-2298. https://doi.org/10.1634/stemcells.2005-0542
|
[15]
|
Hu, C., Zhao, L., Zhang, L., et al. (2020) Mesenchymal Stem Cell-Based Cell-Free Strategies: Safe and Effective Treatments for Liver Injury. Stem Cell Research & Therapy, 11, Article No. 377.
https://doi.org/10.1186/s13287-020-01895-1
|
[16]
|
Porada, C.D., Zanjani, E.D. and Almeida-Porad, G. (2006) Adult Mesenchymal Stem Cells: A Pluripotent Population with Multiple Applications. Current Stem Cell Research & Therapy, 1, 365-369.
https://doi.org/10.2174/157488806778226821
|
[17]
|
Dominici, M., Le Blanc, K., Mueller, I., et al. (2006) Minimal Criteria for Defining Multipotent Mesenchymal Stromal Cells. The International Society for Cellular Therapy Position Statement. Cytotherapy, 8, 315-317.
https://doi.org/10.1080/14653240600855905
|
[18]
|
Phinney, D.G., Di Giuseppe, M., Njah, J., et al. (2015) Mesenchymal Stem Cells Use Extracellular Vesicles to Outsource Mitophagy and Shuttle microRNAs. Nature Com-munications, 6, Article No. 8472.
https://doi.org/10.1038/ncomms9472
|
[19]
|
Kim, J. and Hematti, P. (2009) Mesenchymal Stem Cell-Educated Macrophages: A Novel Type of Alternatively Activated Macrophages. Experimental Hematology, 37, 1445-1453. https://doi.org/10.1016/j.exphem.2009.09.004
|
[20]
|
Nauta, A.J. and Fibbe, W.E. (2007) Immunomodulatory Properties of Mesenchymal Stromal Cells. Blood, 110, 3499-3506. https://doi.org/10.1182/blood-2007-02-069716
|
[21]
|
Galland, S., Vuille, J., Martin, P., et al. (2017) Tumor-Derived Mesenchymal Stem Cells Use Distinct Mechanisms to Block the Activity of Natural Killer Cell Subsets. Cell Reports, 20, 2891-2905.
https://doi.org/10.1016/j.celrep.2017.08.089
|
[22]
|
Consentius, C., Akyuz, L., Schmidt-Lucke, J.A., et al. (2015) Mesenchymal Stromal Cells Prevent Allostimulation in Vivo and Control Checkpoints of Th1 Priming: Migration of Human DC to Lymph Nodes and NK Cell Activation. Stem Cells, 33, 3087-3099. https://doi.org/10.1002/stem.2104
|
[23]
|
Lou, S., Duan, Y., Nie, H., et al. (2021) Mesenchymal Stem Cells: Bio-logical Characteristics and Application in Disease Therapy. Biochimie, 185, 9-21. https://doi.org/10.1016/j.biochi.2021.03.003
|
[24]
|
Kuo, T.K., Hung, S.P., Chuang, C.H., et al. (2008) Stem Cell Therapy for Liver Disease: Parameters Governing the Success of Using Bone Marrow Mesenchymal Stem Cells. Gas-troenterology, 134, 2111-2121.e3.
https://doi.org/10.1053/j.gastro.2008.03.015
|
[25]
|
Dowidar, M., El-Belbasi, H., Ayoub, A., et al. (2017) Bio-chemical and Molecular Studies on Bone Marrow Derived Stromal Stem Cells on Liver Injuries in Rats. Zagazig Vet-erinary Journal, 45, 355-365.
https://doi.org/10.21608/zvjz.2017.7866
|
[26]
|
Li, J., Zhang, L., Xin, J., et al. (2012) Immediate Intraportal Trans-plantation of Human Bone Marrow Mesenchymal Stem Cells Prevents Death from Fulminant Hepatic Failure in Pigs. Hepatology, 56, 1044-1052.
https://doi.org/10.1002/hep.25722
|
[27]
|
Patel, A. and Seetharam, A. (2016) Primary Biliary Cholangitis: Disease Pathogenesis and Implications for Established and Novel Therapeutics. Journal of Clinical and Experimental Hepatology, 6, 311-318.
https://doi.org/10.1016/j.jceh.2016.10.001
|
[28]
|
Hirschfield, G.M. and Gershwin, M.E. (2013) The Immunobiology and Pathophysiology of Primary Biliary Cirrhosis. Annual Review of Pathology, 8, 303-330. https://doi.org/10.1146/annurev-pathol-020712-164014
|
[29]
|
Nevens, F. andreone, P., Mazzella, G., et al. (2016) A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis. The New England Journal of Medicine, 375, 631-643. https://doi.org/10.1056/NEJMoa1509840
|
[30]
|
Shah, R.A. and Kowdley, K.V. (2020) Current and Potential Treatments for Primary Biliary Cholangitis. The Lancet Gastroenterology & Hepatology, 5, 306-315. https://doi.org/10.1016/S2468-1253(19)30343-7
|
[31]
|
He, C., Yang, Y., Zheng, K., et al. (2021) Mesenchymal Stem Cell-Based Treatment in Autoimmune Liver Diseases: Underlying Roles, Advantages and Challenges. Therapeutic Advances in Chronic Disease, 12.
https://doi.org/10.1177/2040622321993442
|
[32]
|
Su, J., Chen, X., Huang, Y., et al. (2014) Phylogenetic Distinc-tion of iNOS and IDO Function in Mesenchymal Stem Cell-Mediated Immunosuppression in Mammalian Species. Cell Death & Differentiation, 21, 388-396.
https://doi.org/10.1038/cdd.2013.149
|
[33]
|
Chabannes, D., Hill, M., Merieau, E., et al. (2007) A Role for Heme Oxygenase-1 in the Immunosuppressive Effect of Adult Rat and Human Mesenchymal Stem Cells. Blood, 110, 3691-3694.
https://doi.org/10.1182/blood-2007-02-075481
|
[34]
|
Nemeth, K., Leelahavanichkul, A., Yuen, P.S., et al. (2009) Bone Marrow Stromal Cells Attenuate Sepsis via Prostaglandin E(2)-Dependent Reprogramming of Host Macrophages to Increase Their Interleukin-10 Production. Nature Medicine, 15, 42-49. https://doi.org/10.1038/nm.1905
|
[35]
|
Sioud, M., Mobergslien, A., Boudabous, A., et al. (2010) Evidence for the Involvement of Galectin-3 in Mesenchymal Stem Cell Suppression of Allogeneic T-Cell Proliferation. Scandinavian Journal of Immunology, 71, 267-274.
https://doi.org/10.1111/j.1365-3083.2010.02378.x
|
[36]
|
Chen, D., Tang, P., Liu, L., et al. (2018) Bone Mar-row-Derived Mesenchymal Stem Cells Promote Cell Proliferation of Multiple Myeloma through Inhibiting T Cell Im-mune Responses via PD-1/PD-L1 Pathway. Cell Cycle, 17, 858-867.
https://doi.org/10.1080/15384101.2018.1442624
|
[37]
|
Orabona, C. and Grohmann, U. (2011) Indoleamine 2,3-Dioxygenase and Regulatory Function: Tryptophan Starvation and Beyond. Methods in Molecular Biology, 677, 269-280. https://doi.org/10.1007/978-1-60761-869-0_19
|
[38]
|
Augello, A., Tasso, R., Negrini, S.M., et al. (2005) Bone Marrow Mesenchymal Progenitor Cells Inhibit Lymphocyte Proliferation by Activation of the Programmed Death 1 Pathway. European Journal of Immunology, 35, 1482-1490.
https://doi.org/10.1002/eji.200425405
|
[39]
|
Italiani, P. and Boraschi, D. (2014) From Monocytes to M1/M2 Mac-rophages: Phenotypical vs. Functional Differentiation. Frontiers in Immunology, 5, Article No. 514. https://doi.org/10.3389/fimmu.2014.00514
|
[40]
|
Wang, L., Li, J., Liu, H., et al. (2013) Pilot Study of Umbilical Cord-Derived Mesenchymal Stem Cell Transfusion in Patients with Primary Biliary Cirrhosis. Journal of Gastroenter-ology and Hepatology, 28, 85-92.
https://doi.org/10.1111/jgh.12029
|
[41]
|
Czaja, A.J. (2006) Autoimmune Liver Disease. Current Opinion in Gas-troenterology, 22, 234-240.
https://doi.org/10.1097/01.mog.0000218959.48064.7f
|
[42]
|
Longhi, M.S., Ma, Y., Mieli-Vergani, G., et al. (2010) Aetiopathogenesis of Autoimmune Hepatitis. Journal of Autoimmunity, 34, 7-14. https://doi.org/10.1016/j.jaut.2009.08.010
|
[43]
|
Strassburg, C.P. (2013) Autoimmune Hepatitis. Digestive Diseases, 31, 155-163. https://doi.org/10.1159/000347211
|
[44]
|
Longhi, M.S., Mitry, R.R., Samyn, M., et al. (2009) Vigorous Activation of Monocytes in Juvenile Autoimmune Liver Disease Escapes the Control of Regulatory T-Cells. Hepatology, 50, 130-142. https://doi.org/10.1002/hep.22914
|
[45]
|
Van Den Brand, F.F., Van Der Veen, K.S., Lissenberg-Witte, B.I., et al. (2019) Adverse Events Related to Low Dose Corticosteroids in Autoimmune Hepatitis. Aliment Pharmacology & Therapeutics, 50, 1120-1126.
https://doi.org/10.1111/apt.15528
|
[46]
|
Lu, F.B., Chen, D.Z., Chen, L., et al. (2019) Attenuation of Experimental Autoimmune Hepatitis in Mice with Bone Mesenchymal Stem Cell-Derived Exosomes Carrying MicroRNA-223-3p. Molecules and Cells, 42, 906-918.
|
[47]
|
Chen, L., Lu, F.B., Chen, D.Z., et al. (2018) BMSCs-Derived miR-223-Containing Exosomes Contribute to Liver Protection in Experimental Autoimmune Hepatitis. Molecular Immunology, 93, 38-46.
https://doi.org/10.1016/j.molimm.2017.11.008
|
[48]
|
Lai, R.C., Chen, T.S. and Lim, S.K. (2011) Mesenchymal Stem Cell Exosome: A Novel Stem Cell-Based Therapy for Cardiovascular Disease. Regenerative Medicine, 6, 481-492. https://doi.org/10.2217/rme.11.35
|
[49]
|
Wang, W., Guo, H., Li, H., et al. (2018) Interleukin-35 Gene-Modified Mesenchymal Stem Cells Protect Concanavalin A-Induced Fulminant Hepatitis by Decreasing the Interferon Gamma Level. Human Gene Therapy, 29, 234-241.
https://doi.org/10.1089/hum.2017.171
|
[50]
|
Lee, Y.A., Wallace, M.C. and Friedman, S.L. (2015) Pathobiology of Liver Fibrosis: A Translational Success Story. Gut, 64, 830-841. https://doi.org/10.1136/gutjnl-2014-306842
|
[51]
|
Trautwein, C., Friedman, S.L., Schuppan, D., et al. (2015) He-patic Fibrosis: Concept to Treatment. Journal of Hepatology, 62, S15-S24. https://doi.org/10.1016/j.jhep.2015.02.039
|
[52]
|
Peng, L., Xie, D.Y., Lin, B.L., et al. (2011) Autologous Bone Marrow Mesenchymal Stem Cell Transplantation in Liver Failure Patients Caused by Hepatitis B: Short-Term and Long-Term Outcomes. Hepatology, 54, 820-828.
https://doi.org/10.1002/hep.24434
|
[53]
|
Sakaida, I., Terai, S., Yamamoto, N., et al. (2004) Transplantation of Bone Marrow Cells Reduces CCl4-Induced Liver Fibrosis in Mice. Hepatology, 40, 1304-1311. https://doi.org/10.1002/hep.20452
|
[54]
|
Banas, A., Teratani, T., Yamamoto, Y., et al. (2007) Adipose Tis-sue-Derived Mesenchymal Stem Cells as a Source of Human Hepatocytes. Hepatology, 46, 219-228. https://doi.org/10.1002/hep.21704
|
[55]
|
Tsochatzis, E.A., Bosch, J. and Burroughs, A.K. (2014) Liver Cirrhosis. The Lancet, 383, 1749-1761.
https://doi.org/10.1016/S0140-6736(14)60121-5
|
[56]
|
Innes, H.A., Hutchinson, S.J., Barclay, S., et al. (2013) Quantifying the Fraction of Cirrhosis Attributable to Alcohol among Chronic Hepatitis C Virus Patients: Implications for Treatment Cost-Effectiveness. Hepatology, 57, 451-460.
https://doi.org/10.1002/hep.26051
|
[57]
|
Ganem, D. and Prince, A.M. (2004) Hepatitis B Virus Infection—Natural History and Clinical Consequences. The New England Journal of Medicine, 350, 1118-1129. https://doi.org/10.1056/NEJMra031087
|
[58]
|
Tsuchida, T. and Friedman, S.L. (2017) Mechanisms of Hepatic Stellate Cell Activation. Nature Reviews Gastroenterology & Hepatology, 14, 397-411. https://doi.org/10.1038/nrgastro.2017.38
|
[59]
|
Kisseleva, T. and Brenner, D. (2021) Molecular and Cellular Mechanisms of Liver Fibrosis and Its Regression. Nature Reviews Gastroenterology & Hepatology, 18, 151-166. https://doi.org/10.1038/s41575-020-00372-7
|
[60]
|
Hernandez-Gea, V. and Friedman, S.L. (2011) Pathogenesis of Liver Fibrosis. Annual Review of Pathology, 6, 425-456.
https://doi.org/10.1146/annurev-pathol-011110-130246
|
[61]
|
Ge, P.S. and Runyon, B.A. (2016) Treatment of Pa-tients with Cirrhosis. The New England Journal of Medicine, 375, 767-777. https://doi.org/10.1056/NEJMra1504367
|
[62]
|
Liaw, Y.F., Sung, J.J., Chow, W.C., et al. (2004) Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease. The New England Journal of Medicine, 351, 1521-1531. https://doi.org/10.1056/NEJMoa033364
|
[63]
|
Gentile, I., Scotto, R., Coppola, C., et al. (2019) Treatment with Direct-Acting Antivirals Improves the Clinical Outcome in Patients with HCV-Related Decompensated Cirrhosis: Results from an Italian Real-Life Cohort (Liver Network Activity-LINA Cohort). Hepatology International, 13, 66-74. https://doi.org/10.1007/s12072-018-9914-6
|
[64]
|
Eom, Y.W., Kim, G. and Baik, S.K. (2015) Mesenchymal Stem Cell Therapy for Cirrhosis: Present and Future Perspectives. World Journal of Gastroenterology, 21, 10253-10261. https://doi.org/10.3748/wjg.v21.i36.10253
|
[65]
|
Terai, S. and Tsuchiya, A. (2017) Status of and Candidates for Cell Therapy in Liver Cirrhosis: Overcoming the “Point of No Return” in Advanced Liver Cirrhosis. Journal of Gastroenterology, 52, 129-140.
https://doi.org/10.1007/s00535-016-1258-1
|
[66]
|
Wang, J., Bian, C., Liao, L., et al. (2009) Inhibition of Hepatic Stellate Cells Proliferation by Mesenchymal Stem Cells and the Possible Mechanisms. Hepatology Research, 39, 1219-1228.
https://doi.org/10.1111/j.1872-034X.2009.00564.x
|
[67]
|
Amer, M.E., El-Sayed, S.Z., El-Kheir, W.A., et al. (2011) Clinical and Laboratory Evaluation of Patients with End-Stage Liver Cell Failure Injected with Bone Marrow-Derived Hepatocyte-Like Cells. European Journal of Gastroenterology & Hepatology, 23, 936-941. https://doi.org/10.1097/MEG.0b013e3283488b00
|
[68]
|
Wang, L., Han, Q., Chen, H., et al. (2014) Allogeneic Bone Marrow Mesenchymal Stem Cell Transplantation in Patients with UDCA-Resistant Primary Biliary Cirrhosis. Stem Cells and Development, 23, 2482-2489.
https://doi.org/10.1089/scd.2013.0500
|
[69]
|
Hare, J.M., Fishman, J.E., Gerstenblith, G., et al. (2012) Comparison of Allogeneic vs Autologous Bone Marrow-Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients with Ischemic Cardiomyopathy: The POSEIDON Randomized Trial. JAMA, 308, 2369-2379. https://doi.org/10.1001/jama.2012.25321
|
[70]
|
Shiota, G. and Itaba, N. (2017) Progress in Stem Cell-Based Therapy for Liver Disease. Hepatology Research, 47, 127-141. https://doi.org/10.1111/hepr.12747
|
[71]
|
Arsenijevic, A., Harrell, C.R., Fellabaum, C., et al. (2017) Mesenchymal Stem Cells as New Therapeutic Agents for the Treatment of Primary Biliary Cholangitis. Analytical Cellular Pathology (Amsterdam), 2017, Article ID: 7492836.
https://doi.org/10.1155/2017/7492836
|